In a similar manner, the MOG peptide model of EAE is widely used to assess drug candidates for multiple sclerosis and serves as a mechanistic model for activation and expansion of self-reactive T cells (Th1, Th17) that induce and propagate injury to the spinal cord of mice. The gene discussed is MOG; the disease is multiple sclerosis.